Skip to main content

Table 6 Studies describing intensive care unit length of stay in patients with resistant and multidrug-resistant Pseudomonas aeruginosa infections

From: Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Author Study groups (n) Median ICU Length of Stay (days) Reported Significance (p-value or 95% CI) Ref
Main findings
Evans et al. (2007) Susceptible P. aeruginosa (73) 6 0.02 [71]
Resistant P. aeruginosac (47) 13
Kaminski et al. (2011) Ureido/carboxypenicillin resistant P. aeruginosa (70) 29 0.37 [66]
Ureido/carboxypenicillin susceptible P. aeruginosa (153) 28.5
Paramythiotou et al. (2004) MDR P. aeruginosad (34) 44.5 (57.0)a,b 0.55 [54]
Control (34) 43.5 (46.9)a,b
  1. a Length of ICU stay (ICU stay matched between cases and controls); b Study reported mean length of stay; c Absence of susceptibility to all the drugs in one or more of the following antibiotic classes: aminoglycosides, cephalosporins, carbapenems, and fluoroquinolones; d Absence of susceptibility to piperacillin, ceftazidime, imipenem, and ciprofloxacin.